{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:24:29Z","timestamp":1757625869782,"version":"3.44.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant","award":["NRF-2022R1A2C1003039"],"award-info":[{"award-number":["NRF-2022R1A2C1003039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/s12868-025-00978-0","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:01:05Z","timestamp":1756375265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative study of 18F-labeled PET radiopharmaceuticals in an Alzheimer\u2019s disease mouse model"],"prefix":"10.1186","volume":"26","author":[{"given":"Bok-Nam","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Sil","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","volume":"65","author":"VJ De-Paula","year":"2012","unstructured":"De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer\u2019s disease. Subcell Biochem. 2012;65:329\u201352.","journal-title":"Subcell Biochem"},{"issue":"4","key":"978_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12779\/dnd.2016.15.4.115","volume":"15","author":"HD Yang","year":"2016","unstructured":"Yang HD, Kim DH, Lee SB, Young LD. History of Alzheimer\u2019s disease. Dement Neurocogn Disord. 2016;15(4):115\u201321.","journal-title":"Dement Neurocogn Disord"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1192\/bjp.174.1.51","volume":"174","author":"E Souetre","year":"1999","unstructured":"Souetre E, Thwaites RM, Yeardley HL. Economic impact of alzheimer\u2019s disease in the united kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer\u2019s disease. Br J Psychiatry. 1999;174:51\u20135.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"978_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/ggi.13764","volume":"19","author":"H Takechi","year":"2019","unstructured":"Takechi H, Kokuryu A, Kuzuya A, Matsunaga S. Increase in direct social care costs of Alzheimer\u2019s disease in Japan depending on dementia severity. Geriatr Gerontol Int. 2019;19(10):1023\u20139.","journal-title":"Geriatr Gerontol Int"},{"key":"978_CR5","doi-asserted-by":"crossref","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 2020, 25(24).","DOI":"10.3390\/molecules25245789"},{"key":"978_CR6","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397.","journal-title":"J Cent Nerv Syst Dis"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","volume":"52","author":"SH Barage","year":"2015","unstructured":"Barage SH, Sonawane KD. Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer\u2019s disease. Neuropeptides. 2015;52:1\u201318.","journal-title":"Neuropeptides"},{"issue":"2","key":"978_CR8","first-page":"179","volume":"121","author":"K Imahori","year":"1997","unstructured":"Imahori K, Uchida T. Physiology and pathology of Tau protein kinases in relation to Alzheimer\u2019s disease. J Biochem. 1997;121(2):179\u201388.","journal-title":"J Biochem"},{"issue":"40","key":"978_CR9","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in Transgenic mice with five Familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"8","key":"978_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21(8):726\u201334.","journal-title":"Lancet Neurol"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"872509","DOI":"10.3389\/fnins.2022.872509","volume":"16","author":"B Chen","year":"2022","unstructured":"Chen B, Marquez-Nostra B, Belitzky E, Toyonaga T, Tong J, Huang Y, Cai Z. PET imaging in animal models of Alzheimer\u2019s disease. Front Neurosci. 2022;16:872509.","journal-title":"Front Neurosci"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fmed.2020.00529","volume":"7","author":"TN Franke","year":"2020","unstructured":"Franke TN, Irwin C, Bayer TA, Brenner W, Beindorff N, Bouter C, Bouter Y. In vivo imaging with (18)F-FDG- and (18)F-Florbetaben-PET\/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer\u2019s disease. Front Med (Lausanne). 2020;7:529.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"978_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.2967\/jnumed.112.110163","volume":"54","author":"A Snellman","year":"2013","unstructured":"Snellman A, Lopez-Picon FR, Rokka J, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M. Longitudinal amyloid imaging in mouse brain with 11\u00a0C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. J Nucl Med. 2013;54(8):1434\u201341.","journal-title":"J Nucl Med"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13550-014-0037-3","volume":"4","author":"A Snellman","year":"2014","unstructured":"Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M. In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer\u2019s disease with a high specific activity PET imaging agent [(18)F]flutemetamol. EJNMMI Res. 2014;4:37.","journal-title":"EJNMMI Res"},{"issue":"1","key":"978_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.dadm.2014.11.004","volume":"1","author":"JM Yeo","year":"2015","unstructured":"Yeo JM, Waddell B, Khan Z, Pal S. A systematic review and meta-analysis of (18)F-labeled amyloid imaging in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2015;1(1):5\u201313.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"978_CR16","first-page":"268","volume":"8","author":"L Filippi","year":"2018","unstructured":"Filippi L, Chiaravalloti A, Bagni O, Schillaci O. (18)F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer\u2019s disease. Am J Nucl Med Mol Imaging. 2018;8(4):268\u201381.","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"3","key":"978_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3988\/jcn.2022.0207","volume":"19","author":"K Baik","year":"2023","unstructured":"Baik K, Jeon S, Park M, Lee YG, Lee PH, Sohn YH, Ye BS. Comparison between (18)F-Florapronol and (18)F-Florbetaben imaging in patients with cognitive impairment. J Clin Neurol. 2023;19(3):260\u20139.","journal-title":"J Clin Neurol"},{"issue":"1","key":"978_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12868-018-0447-7","volume":"19","author":"HJ Son","year":"2018","unstructured":"Son HJ, Jeong YJ, Yoon HJ, Lee SY, Choi GE, Park JA, Kim MH, Lee KC, Lee YJ, Kim MK, et al. Assessment of brain beta-amyloid deposition in Transgenic mouse models of Alzheimer\u2019s disease with PET imaging agents (18)F-flutemetamol and (18)F-florbetaben. BMC Neurosci. 2018;19(1):45.","journal-title":"BMC Neurosci"},{"issue":"5","key":"978_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000536089","volume":"114","author":"S Zhu","year":"2024","unstructured":"Zhu S, Pang Y, Zhang X, Yang C, Gao J, Fang P, Zhang Y, Yao Y, Ju F, Ye F, et al. Alteration of thyroid hormones in mouse models of Alzheimer\u2019s disease and aging. Neuroendocrinology. 2024;114(5):411\u201322.","journal-title":"Neuroendocrinology"},{"key":"978_CR20","doi-asserted-by":"crossref","unstructured":"Deng P, Fan T, Gao P, Peng Y, Li M, Li J, Qin M, Hao R, Wang L, Li M et al. SIRT5-Mediated desuccinylation of RAB7A protects against cadmium-induced Alzheimer\u2019s Disease-like pathology by restoring autophagic flux. Adv Sci (Weinh) 2024:e2402030.","DOI":"10.1002\/advs.202402030"},{"key":"978_CR21","doi-asserted-by":"publisher","first-page":"122457","DOI":"10.1016\/j.lfs.2024.122457","volume":"340","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qi H, Jia D, Zhao J, Xu C, Liu J, Cui Y, Zhang J, Wang M, Chen M, et al. Cognitive impairment in Alzheimer\u2019s disease FAD(4T) mouse model: synaptic loss facilitated by activated microglia via C1qA. Life Sci. 2024;340:122457.","journal-title":"Life Sci"},{"key":"978_CR22","doi-asserted-by":"crossref","unstructured":"Park BN, Kim GH, Ko SA, Shin GH, Lee SJ, An YS, Yoon JK. Zr-89 Immuno-PET targeting ectopic ATP synthase enables in-vivo imaging of tumor angiogenesis. Int J Mol Sci 2019;20(16).","DOI":"10.3390\/ijms20163928"},{"issue":"1","key":"978_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroimage.2007.06.032","volume":"38","author":"MM Mirrione","year":"2007","unstructured":"Mirrione MM, Schiffer WK, Fowler JS, Alexoff DL, Dewey SL, Tsirka SE. A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. NeuroImage. 2007;38(1):34\u201342.","journal-title":"NeuroImage"},{"issue":"4","key":"978_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.neuroscience.2005.07.014","volume":"135","author":"Y Ma","year":"2005","unstructured":"Ma Y, Hof PR, Grant SC, Blackband SJ, Bennett R, Slatest L, McGuigan MD, Benveniste H. A three-dimensional digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy. Neuroscience. 2005;135(4):1203\u201315.","journal-title":"Neuroscience"},{"issue":"9","key":"978_CR25","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1021\/acs.molpharmaceut.7b00351","volume":"14","author":"SJ Oh","year":"2017","unstructured":"Oh SJ, Kim MH, Han SJ, Kang KJ, Ko IO, Kim Y, Park JA, Choi JY, Lee KC, Chi DY, et al. Preliminary PET study of (18)F-FC119S in normal and Alzheimer\u2019s disease models. Mol Pharm. 2017;14(9):3114\u201320.","journal-title":"Mol Pharm"},{"issue":"2","key":"978_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15761\/JSIN.1000123","volume":"2","author":"H Qosa","year":"2016","unstructured":"Qosa H, Kaddoumi A. Effect of mouse strain as a background for Alzheimer\u2019s disease models on the clearance of amyloid-beta. J Syst Integr Neurosci. 2016;2(2):135\u201340.","journal-title":"J Syst Integr Neurosci"},{"issue":"4","key":"978_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.semnuclmed.2011.03.001","volume":"41","author":"J Lister-James","year":"2011","unstructured":"Lister-James J, Pontecorvo MJ, Clark C, Joshi AD, Mintun MA, Zhang W, Lim N, Zhuang Z, Golding G, Choi SR, et al. Florbetapir f-18: a histopathologically validated beta-amyloid positron emission tomography imaging agent. Semin Nucl Med. 2011;41(4):300\u20134.","journal-title":"Semin Nucl Med"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-025-00978-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:36:44Z","timestamp":1757446604000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-025-00978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1186\/s12868-025-00978-0","relation":{},"ISSN":["1471-2202"],"issn-type":[{"type":"electronic","value":"1471-2202"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Institutional Animal Care and Use Committee of Ajou University School of Medicine, Suwon, Republic of Korea (IACUC No. 2022-0017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}